Skip to content
Blerp – Lifestyle
Author:
Imbria Pharmaceuticals Inc.
Imbria Pharmaceuticals Receives FDA Orphan Drug Designation for Ninerafaxstat for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
June 24, 2026